DOI: 10.1001/jamanetworkopen.2026.36756 ISSN: 2574-3805
Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT
Otto Simonsson, Melissa Bradley, Joshua C. Black, Karilynn M. Rockhill, Andrew A. Monte, Peter S. HendricksThis cross-sectional study describes health outcomes attributed to recent use of psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), ibogaine, and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a nationally representative survey of US adults.